Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | President, US Pharma | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 334,853 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Sale · Disposed 36,827 · Balance 334,853 F1: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 20, 2026 20:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 36,827 | $7.03 | $258,893.81 |
DisclosureSEC source: 0000885590-26-000109 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · President, US Pharma 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,853 F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 21, 2026. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 20:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,260 | $4.83 | $25,405.80 |
DisclosureSEC source: 0000885590-26-000101 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · President, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,680 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:23 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 23,395 | $4.89 | $114,401.55 |
DisclosureSEC source: 0000885590-26-000099 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · President, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,940 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 22:21 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 17,578 | $6.04 | $106,171.12 |
DisclosureSEC source: 0000885590-26-000033 · form4.xml · nonDerivative · entry 2 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,335 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:21 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 157,139 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000033 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,913 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 21:02 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 30,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-019420 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,774 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 21:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 22,736 | $6.42 | $145,965.12 |
DisclosureSEC source: 0001127602-25-019278 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,927 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 108,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007290 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,663 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 144,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020566 · form4.xml · nonDerivative · entry 1 Lenar Aimee J. · CIK 0002029927 · EVP, US Pharma 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,352 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.